RedHill Biopharma jumps on $18 million Talicia sale to Apotex

RedHill Biopharma Ltd. (RDHL) is up 66.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is RedHill’s August 31, 2026 announcement that it sold its 70% stake in the Talicia business to Apotex for $18 million in cash upfront, plus up to $35 million in potential sales-based milestone payments. For a micro-cap biotech, that immediate cash infusion appears to have improved the market’s view of liquidity, while management also framed the deal as a way to fund commercial expansion and move faster toward profitability.

Details:

RedHill disclosed in a Form 6-K that it divested its 70% interest in Talicia Holdings to Apotex for $18 million upfront and possible additional milestone payments tied to worldwide net sales.

The filing also said Apotex already controlled the remaining 30% stake after its prior transaction involving Cumberland’s branded U.S. business, simplifying ownership of the asset.

Management described the deal as a strategic repositioning that strengthens liquidity and supports the next phase of its commercial business expansion.

Earlier company materials showed RedHill ended 2025 with $4.1 million in cash, so the new proceeds are sizable relative to its recent balance-sheet scale.

Sources:

SEC, RedHill Biopharma, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$RDHL Insider Trading Activity

$RDHL insiders have traded $RDHL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $RDHL stock by insiders over the last 6 months:

GILEAD RADAY (Chief Operating Officer) has made 0 purchases and 2 sales selling 29,870,000 shares for an estimated $2,987.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RDHL Hedge Fund Activity

We have seen 7 institutional investors add shares of $RDHL stock to their portfolio, and 10 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

YORKVILLE ADVISORS GLOBAL, LP removed 228,739 shares (-65.2%) from their portfolio in Q2 2026, for an estimated $193,284
CITADEL ADVISORS LLC added 44,648 shares (+216.0%) to their portfolio in Q2 2026, for an estimated $37,727
XTX TOPCO LTD removed 15,163 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $12,812
STONEX GROUP INC. removed 14,481 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $12,236
TWO SIGMA SECURITIES, LLC removed 13,019 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $11,001
LIDO ADVISORS, LLC added 11,009 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,302
RHUMBLINE ADVISERS added 8,639 shares (+168.9%) to their portfolio in Q2 2026, for an estimated $7,299

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.